ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,567.19
      1.06%
      US Tech 100
      19,828.00
      0.95%
      Dow Jones
      39,375.87
      0.17%
      Brent Oil
      86.775
      0.00%
      Bitcoin
      56,818.01
      0.30%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. uniQure NV (QURE)

      7. uniQure NV (QURE) News

      QURE

      uniQure NV (QURE)

      uniQure NV
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:QURE
      DateTimeSourceHeadlineSymbolCompany
      05/09/20177:00AMGlobeNewswireuniQure Announces First Quarter 2017 Financial Results and Highlights Recent Company ProgressNASDAQ:QUREuniQure NV
      05/09/20177:00AMGlobeNewswire Inc.uniQure Announces First Quarter 2017 Financial Results and Highlights Recent Company ProgressNASDAQ:QUREuniQure NV
      05/01/20175:09PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:QUREuniQure NV
      05/01/20175:08PMEdgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:QUREuniQure NV
      05/01/20177:00AMGlobeNewswireuniQure Announces Company Presentations at Upcoming May ConferencesNASDAQ:QUREuniQure NV
      05/01/20177:00AMGlobeNewswire Inc.uniQure Announces Company Presentations at Upcoming May ConferencesNASDAQ:QUREuniQure NV
      04/26/20177:00AMGlobeNewswireuniQure Presents New Preclinical Data on AMT-130 in Huntington's Disease at CHDI's 12th Annual Huntington's Disease Therapeut...NASDAQ:QUREuniQure NV
      04/26/20177:00AMGlobeNewswire Inc.uniQure Presents New Preclinical Data on AMT-130 in Huntington’s Disease at CHDI’s 12th Annual Huntington’s Disease The...NASDAQ:QUREuniQure NV
      04/25/20177:05AMGlobeNewswireuniQure Receives European Medicines Agency Priority Medicines (PRIME) Designation for AMT-060 in Hemophilia BNASDAQ:QUREuniQure NV
      04/25/20177:05AMGlobeNewswire Inc.uniQure Receives European Medicines Agency Priority Medicines (PRIME) Designation for AMT-060 in Hemophilia BNASDAQ:QUREuniQure NV
      04/24/20174:05PMGlobeNewswireuniQure Announces Presentations at the Upcoming Annual Meeting of The American Society of Gene and Cell Therapy (ASGCT)NASDAQ:QUREuniQure NV
      04/24/20174:05PMGlobeNewswire Inc.uniQure Announces Presentations at the Upcoming Annual Meeting of The American Society of Gene and Cell Therapy (ASGCT)NASDAQ:QUREuniQure NV
      04/20/20174:10PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:QUREuniQure NV
      04/20/20177:00AMGlobeNewswireuniQure Announces It Will Not Seek Marketing Authorization Renewal for Glybera in EuropeNASDAQ:QUREuniQure NV
      04/20/20177:00AMGlobeNewswire Inc.uniQure Announces It Will Not Seek Marketing Authorization Renewal for Glybera in EuropeNASDAQ:QUREuniQure NV
      04/18/20176:43AMEdgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:QUREuniQure NV
      04/04/20172:33PMGlobeNewswireuniQure Announces Presentations at Upcoming April ConferencesNASDAQ:QUREuniQure NV
      04/04/20177:49AMGlobeNewswireuniQure Publishes Data Demonstrating Wide Distribution of AAV5 in the Central Nervous SystemNASDAQ:QUREuniQure NV
      04/04/20177:42AMGlobeNewswire Inc.uniQure Publishes Data Demonstrating Wide Distribution of AAV5 in the Central Nervous SystemNASDAQ:QUREuniQure NV
      04/03/20177:00AMGlobeNewswire Inc.uniQure Announces Presentations at Upcoming April ConferencesNASDAQ:QUREuniQure NV
      03/31/20176:01AMEdgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:QUREuniQure NV
      03/28/20174:21PMEdgar (US Regulatory)Withdrawal of Registration Statement (ammendment) (aw)NASDAQ:QUREuniQure NV
      03/27/20174:19PMEdgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:QUREuniQure NV
      03/27/20174:16PMEdgar (US Regulatory)Withdrawal of Registration Statement (ammendment) (aw)NASDAQ:QUREuniQure NV
      03/15/20179:18AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:QUREuniQure NV
      03/15/20178:29AMEdgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:QUREuniQure NV
      03/15/20178:09AMEdgar (US Regulatory)Securities Registration (foreign Private Issuer) (f-3/a)NASDAQ:QUREuniQure NV
      03/15/20177:54AMEdgar (US Regulatory)Annual Report (10-k)NASDAQ:QUREuniQure NV
      03/15/20177:00AMGlobeNewswireuniQure Announces 2016 Financial Results and Provides Update on Company ProgressNASDAQ:QUREuniQure NV
      03/15/20177:00AMGlobeNewswire Inc.uniQure Announces 2016 Financial Results and Provides Update on Company ProgressNASDAQ:QUREuniQure NV
       Showing the most relevant articles for your search:NASDAQ:QURE